The global Glaucoma Therapeutics Market, valued at USD 7.25 million in 2023, is on a robust growth trajectory and is expected to reach USD 9.62 million by 2031. This represents a compound annual growth rate (CAGR) of 3.6% over the forecast period from 2024 to 2031.
Key Players
Some major players in Glaucoma Therapeutics Market are Merck & Co. Inc, Allergan, Bausch & Lomb...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek